Sunday, August 31, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Positive Analyst Evaluations and Price Targets for Sprout Social NASDAQSPT

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Technology Robotics Stock Market Today
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of January 19, 2024, the evaluations and price targets for Sprout Social (NASDAQ:SPT) have been largely positive, according to analysts. Here are the key insights:

Analyst Ratings
– Total Ratings: 1 Bullish, 4 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish.
– Last 30 Days: 1 Bullish, 0 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish.
– 1 Month Ago: 0 Bullish, 2 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish.
– 2 Months Ago: No ratings.
– 3 Months Ago: 0 Bullish, 2 Somewhat Bullish, 0 Indifferent, 0 Somewhat Bearish, 0 Bearish.

Price Targets
The average 12-month price target is $68.8, with a high estimate of $75.00 and a low estimate of $58.00. This indicates a 19.13% increase from the previous average price target of $57.75.

Key Analyst Actions
– Scott Berg from Needham maintains a Buy rating with a price target of $75.00.
– Raimo Lenschow from Barclays raises the rating to Overweight with a price target of $75.00.
– Brett Knoblauch from Cantor Fitzgerald raises the rating to Overweight with a price target of $74.00.
– Clarke Jeffries from Piper Sandler raises the rating to Overweight with a price target of $62.00.
– Michael Turits from Keybanc lowers the rating to Overweight with a price target of $58.00.

The consensus rating for Sprout Social is a Moderate Buy, based on 8 buy ratings, 1 hold rating, and no sell ratings. Analysts’ 12-month forecasts predict a potential upside of 30.54% for the stock.

SPT Stock: Potential Buying Opportunity as Price Holds Steady Above 200-Day Moving Average

On January 19, 2024, SPT stock opened at $61.12, $1.05 higher than its previous close. Throughout the day, the price of SPT shares declined by $0.92 or 1.54% since the market last closed. Despite this drop, SPT is currently trading in the middle of its 52-week range, indicating stability. Additionally, SPT is trading above its 200-day moving average, which suggests positive long-term trends. Investors may see this as a potential buying opportunity. It is important to conduct thorough research and analysis before making any investment decisions.

SPT Stock Performance Analysis: Total Revenue Growth and Net Income Decline in January 19, 2024

Title: SPT Stock Performance on January 19, 2024: A Closer Look

Introduction:
On January 19, 2024, SPT (fictional stock) experienced notable fluctuations in its financial performance. This article aims to analyze the stock’s revenue, net income, and earnings per share (EPS) figures, comparing them to the previous year and the previous quarter.

Total Revenue Growth:
SPT’s total revenue for the past year stood at $253.83 million, marking a significant increase of 35.12% compared to the previous year’s figures. Moreover, the total revenue also witnessed a 7.84% increase since the previous quarter.

Net Income Decline:
Unfortunately, SPT’s net income figures for the same periods did not fare as well. Over the past year, the company reported a net income of -$50.24 million, reflecting a significant decrease of 75.04% compared to the previous year. This decline indicates that SPT faced challenges in managing its expenses and generating profits. The situation worsened in the most recent quarter, with net income plummeting by 75.87% to -$23.01 million.

Earnings per Share (EPS) Deterioration:
The earnings per share (EPS) figures for SPT also experienced a downturn. Over the past year, the EPS stood at -$0.92, marking a decline of 72.35% compared to the previous year. Similarly, in the most recent quarter, the EPS declined by 74.81% to -$0.41, indicating a further deterioration in earnings.

Conclusion:
SPT’s stock performance on January 19, 2024, showcased mixed results. While the company achieved a commendable 35.12% growth in total revenue compared to the previous year, its net income and earnings per share figures experienced significant declines. The decrease in net income by 75.04% over the past year and 75.87% in the most recent quarter raises concerns about the company’s profitability and financial stability. Furthermore, the decline in earnings per share by 72.35% over the past year and 74.81% in the most recent quarter indicates a further erosion of profitability per outstanding share.

Investors and stakeholders should closely monitor SPT’s financial performance in the coming months to assess whether these negative trends continue or if the company can implement strategies to reverse the decline in net income and earnings per share. It is essential to consider these figures in conjunction with other relevant factors before making any investment decisions related to SPT stock.

Tags: SPT
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Banking (2)

RBC Capital Analyst Reiterates Outperform Rating and Sets 42 Price Target for Synovus Financial

Insurance company Markets and money

Analysts Bullish on Allstate NYSE ALL with Increasing Price Targets

Banking Markets and money

Keefe Bruyette Woods Analyst Reaffirms Market Perform Rating for Westamerica Bancorp with Adjusted Price Target

Recommended

Biotechnology Stock Bull Market

Novavax Implements Major Changes to Operations and Finances in Response to Market Conditions

2 years ago
Healthcare-IT-and-tech

Revolutionizing Healthcare Accessibility with the MGMini A Collaboration Between KORE and Medical Guardian

2 years ago
Finance_Banking (2)

Deutsche Bank Analyst Initiates Coverage on Sabra Health Care REIT with a Buy Rating and 21 Price Target

2 years ago

ETF Managers Group Decreases Stake in Sunrun Inc. Despite Mixed Analyst Reviews on Company’s Performance

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe ADSK Alibaba AMD AMZN Apple AVGO BA Broadcom C Coinbase COST CRWD DIS DWAC Eli Lilly GM IBM INTC Intel Kraft Heinz LLY Lockheed META Micron MP Materials MSFT NFLX NIO Nvidia NVO Opendoor Oracle Palantir PLTR Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla TGT Tilray TSLA
No Result
View All Result

Highlights

Semiconductor Sector Faces Regulatory Uncertainty as Court Ruling and Export Controls Collide

Essential Utilities: A Defensive Haven Amid Market Volatility

Acquisition Battle Intensifies for Fintech Firm MeridianLink

JBG Smith Properties Stock Soars Despite Mounting Concerns

Rent the Runway’s Radical Financial Overhaul: A Rescue with Significant Shareholder Costs

Nvidia Shares Face Pressure Despite Record-Breaking Performance

Trending

WM Technology Stock
Cannabis

A Tale of Two Quarters: WM Technology’s Profit Surge Amid Revenue Challenges

by Robert Sasse
August 31, 2025
0

WM Technology, a pioneer in cannabis technology, finds itself navigating a complex financial landscape. The company's second-quarter...

Watsco Stock

Watsco Shares Face Pressure Following Quarterly Earnings Miss

August 31, 2025
Agora Stock

Agora Shares Face Market Skepticism Despite Turning a Profit

August 31, 2025
Texas Instruments Stock

Semiconductor Sector Faces Regulatory Uncertainty as Court Ruling and Export Controls Collide

August 31, 2025
Essential Utilities Stock

Essential Utilities: A Defensive Haven Amid Market Volatility

August 31, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • A Tale of Two Quarters: WM Technology’s Profit Surge Amid Revenue Challenges August 31, 2025
  • Watsco Shares Face Pressure Following Quarterly Earnings Miss August 31, 2025
  • Agora Shares Face Market Skepticism Despite Turning a Profit August 31, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com